Schedule 13D ownership disclosure

ACADIA Pharmaceuticals Inc

Common Stock, $0.0001 par value per share · CUSIP: 004225108

Event date: 2026-02-24

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Baker Bros. Advisors LPReported CIK 0001263508

    Shares: 43,151,054.00 · Class: 25.3%

  • Baker Bros. Advisors (GP) LLCReported CIK 0001580575

    Shares: 43,151,054.00 · Class: 25.3%

  • Julian C. BakerReported CIK 0001087939

    Shares: 43,294,373.00 · Class: 25.4%

  • Felix J. BakerReported CIK 0001087940

    Shares: 43,294,373.00 · Class: 25.4%

  • FBB3 LLCReported CIK 0001625395

    Shares: 40,443.00 · Class: 0.02%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-26-020778
Form type
SCHEDULE 13D/A
Filer
ACADIA PHARMACEUTICALS INC
CIK
CIK 1070494
Filed
Feb 26, 2026
Reporting period
Feb 24, 2026
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub